openPR Logo
Press release

Pulmonary Drugs Market to Signify Strong Growth by 2023-2029

09-12-2023 12:25 PM CET | Health & Medicine

Press release from: Orion Market Research

Pulmonary Drugs Market to Signify Strong Growth by 2023-2029

Pulmonary drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to fuel the market growth include a rise in the prevalence of chronic diseases such as bronchitis, tuberculosis, and chronic obstructive pulmonary disease and a rise in tobacco smoking. Pulmonary drug delivery systems deliver drugs to the lung for the treatment of respiratory tract diseases. This route is preferred broadly owing to the non-invasive technique, high blood circulation, large surface area for absorption, and permeability rate. Recent advancements in pulmonary drug delivery devices and methods, rise in gastrointestinal upset, respiratory diseases, and minimum dose requirement are the driving factors that will accelerate the growth of the market during the forecast period. 

Moreover, rising incidences of chronic respiratory diseases will surge the demand for pulmonary drugs. As per the Global Asthma Report 2018, around 339 million people are affected by Asthma globally. The significant increase in the targeted patient pool will promote the demand for pulmonary drugs. Furthermore, R&D associated with the pulmonary drugs coupled with government and non-government initiatives will create lucrative opportunities for the market in the coming years, which in turn are expected to boost the market growth during the forecast period. For instance, CDC's National Asthma Control Program (NACP) provides funds for educating asthma-affected patients. Such initiatives are likely to raise awareness about asthma, which will increase the adoption of pulmonary drugs in the treatment of chronic obstructive pulmonary disease (COPD) and asthma, leading to the growth of the global pulmonary drugs market.

To Request a Sample of our Report on Pulmonary Drugs Market:  https://www.omrglobal.com/request-sample/pulmonary-drugs-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered
Regions Covered- Globally
Competitive Landscape:GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Novartis AG, Merck & Co., Inc., and AstraZeneca plc. 

Pulmonary Drugs Market Report by Segment

By Drug Class 

Beta-2 Agonists
Anticholinergic Agents
Oral and Inhaled Corticosteroids
Anti-leukotrienes
Antihistamines
Monoclonal Antibodies
Combination Drugs
Others

By Indication 

Asthma
COPD (Chronic Obstructive Pulmonary Disease
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Others

By Distribution Channel 

Hospital Pharmacies
Retail Pharmacies
Others

A full Report of Pulmonary Drugs Market is Available at:  https://www.omrglobal.com/industry-reports/pulmonary-drugs-market

 Pulmonary Drugs Market by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://www.somosxbox.com.mx/noticias-urgente/el-mercado-de-cubiertas-moviles-sera-testigo-de-un-crecimiento-asombroso-para-2029/120862/
https://perualdia.net/tasa-de-crecimiento-lento-del-mercado-de-cocinas-modulares-previsto-para-2023-2030/
https://ekz-crosstour.ch/news/der-markt-fuer-insektenschutzmittel-wird-bis-2023-2029-ein-starkes-wachstum-verzeichnen/129165/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Drugs Market to Signify Strong Growth by 2023-2029 here

News-ID: 3204897 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Pulmonary

Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028. The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments